HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$21.00
Day range
$20.17 - $21.42
Year range
$15.19 - $27.29
Market cap
2.17B USD
Avg Volume
710.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 12.77M | 1,490.54% |
Operating expense | 56.00M | 7.95% |
Net income | -92.18M | -86.23% |
Net profit margin | -721.71 | 88.29% |
Earnings per share | -0.90 | — |
EBITDA | -43.18M | 15.44% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 834.19M | 145.03% |
Total assets | 864.62M | 149.10% |
Total liabilities | 107.12M | 82.47% |
Total equity | 757.50M | — |
Shares outstanding | 109.82M | — |
Price to book | 3.00 | — |
Return on assets | -16.58% | — |
Return on capital | -19.00% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -92.18M | -86.23% |
Cash from operations | -37.48M | -13.32% |
Cash from investing | -62.18M | -2,072,533.33% |
Cash from financing | 456.61M | — |
Net change in cash | 349.01M | 1,352.88% |
Free cash flow | 33.80M | — |
About
Founded
2019
Website
Employees
68
